|Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis|
S Sawcer, G Hellenthal, M Pirinen, CCA Spencer, NA Patsopoulos, ...
Nature 476 (7359), 214, 2011
|Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.|
Nature Genetics 45 (11), 1353-1360, 2013
|Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind …|
G Comi, V Martinelli, M Rodegher, L Moiola, O Bajenaru, A Carra, ...
The Lancet 374 (9700), 1503-1511, 2009
|Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled …|
L Kappos, G Comi, H Panitch, J Oger, J Antel, P Conlon, L Steinman, ...
Nature medicine 6 (10), 1176, 2000
|Default-mode network dysfunction and cognitive impairment in progressive MS|
MA Rocca, P Valsasina, M Absinta, G Riccitelli, ME Rodegher, P Misci, ...
Neurology 74 (16), 1252-1259, 2010
|Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis|
G Comi, M Filippi, V Martinelli, A Campi, M Rodegher, M Alberoni, ...
Journal of the neurological sciences 132 (2), 222-227, 1995
|Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images|
M Rovaris, M Filippi, G Calori, M Rodegher, A Campi, B Colombo, G Comi
Journal of neurology 244 (4), 266-270, 1997
|Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests|
A Ghezzi, V Martinelli, V Torri, M Zaffaroni, M Rodegher, G Comi, A Zibetti, ...
Journal of neurology 246 (9), 770-775, 1999
|Long-term changes of magnetization transfer–derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis|
MA Rocca, G Mastronardo, M Rodegher, G Comi, M Filippi
American journal of neuroradiology 20 (5), 821-827, 1999
|Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype|
G Riccitelli, MA Rocca, E Pagani, ME Rodegher, P Rossi, A Falini, G Comi, ...
Human brain mapping 32 (10), 1535-1543, 2011
|Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome|
G Comi, V Martinelli, M Rodegher, L Moiola, L Leocani, O Bajenaru, ...
Multiple Sclerosis Journal 19 (8), 1074-1083, 2013
|Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T1, T2 and MT histograms|
G Iannucci, L Minicucci, M Rodegher, MP Sormani, G Comi, M Filippi
Journal of the neurological sciences 171 (2), 121-129, 1999
|Paraclinical tests in acute‐onset optic neuritis: basal data and results of a short follow‐up|
V Martinelli, G Comi, M Filippi, A Poggi, B Colombo, M Rodegher, G Scotti, ...
Acta neurologica scandinavica 84 (3), 231-236, 1991
|Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1‐‐‐weighted MRI|
A Gass, M Filippi, ME Rodegher, A Schwartz, G Comi, MG Hennerici
Neurology 50 (2), 548-550, 1998
|Mitoxantrone: benefits and risks in multiple sclerosis patients|
V Martinelli, M Radaelli, L Straffi, M Rodegher, G Comi
Neurological sciences 30 (2), 167, 2009
|Functional cortical changes of the sensorimotor network are associated with clinical recovery in multiple sclerosis|
DM Mezzapesa, MA Rocca, M Rodegher, G Comi, M Filippi
Human brain mapping 29 (5), 562-573, 2008
|A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis|
M Gironi, F Martinelli-Boneschi, P Sacerdote, C Solaro, M Zaffaroni, ...
Multiple Sclerosis Journal 14 (8), 1076-1083, 2008
|Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis|
V Martinelli, M Rodegher, L Moiola, G Comi
Neurological Sciences 25 (4), s350-s355, 2004
|MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers|
F Martinelli-Boneschi, C Fenoglio, P Brambilla, M Sorosina, G Giacalone, ...
Neuroscience letters 508 (1), 4-8, 2012
|Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis|
C Gobbi, MA Rocca, G Riccitelli, E Pagani, R Messina, P Preziosa, ...
Multiple Sclerosis Journal 20 (2), 192-201, 2014